GlassScriptPhysician profile
Adolphus S Bonar
NPI 1578559373
$1,717.85
in general payments reported to CMS, 2019-2025
17 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $753 · 2020: $28.16 · 2021: $323 · 2022: $47.14 · 2023: $122 · 2024: $169 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $273.51 | 2023-2024 | Minimed 780g |
| Corcept Therapeutics | $239.41 | 2019 | |
| Amarin Pharma, INC. | $188.04 | 2019 | |
| Amgen INC. | $156.74 | 2019 | |
| Beta Bionics, INC. | $150.77 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.20 | 2019-2025 | Jardiance |
| Clarus Therapeutics INC. | $114.99 | 2021 | |
| Novo Nordisk INC | $78.87 | 2021 | |
| Acella Pharmaceuticals, LLC | $68.15 | 2020-2021 | |
| Esperion Therapeutics, INC. | $64.66 | 2021 | |
| Sanofi-Aventis U.S. LLC | $61.79 | 2019 | |
| Companion Medical, INC. | $57.90 | 2019 | |
| Xeris Pharmaceuticals, INC. | $47.14 | 2022 | |
| Horizon Therapeutics Plc | $24.26 | 2021 | |
| Senseonics, Incorporated | $18.00 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $17.84 | 2023 | Omnipod |
| Abbott Laboratories | $16.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adolphus Bonar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.